Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

about

Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.

P2860

Q47156096-F3D9F660-CF78-4B76-A6FD-8C7E528E991D

P2860

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

Item

http://www.wikidata.org/entity/Q40180205

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

@en

type

Item

label

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

@en

prefLabel

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

@en

P1476

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

@en

P2093

A Ari Hakimi

http://www.w3.org/2001/XMLSchema#string

Alison M Schram

http://www.w3.org/2001/XMLSchema#string

Chung-Han Lee

http://www.w3.org/2001/XMLSchema#string

Gouri J Nanjangud

http://www.w3.org/2001/XMLSchema#string

James J Hsieh

http://www.w3.org/2001/XMLSchema#string

Joshua Chaim

http://www.w3.org/2001/XMLSchema#string

Kaitlin Woo

http://www.w3.org/2001/XMLSchema#string

Maria I Carlo

http://www.w3.org/2001/XMLSchema#string

Martin H Voss

http://www.w3.org/2001/XMLSchema#string

Robert J Motzer

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

The Polycomb complex PRC2 and its mark in life

Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.

Aberrations of EZH2 in cancer.

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation

Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

P304

e987-e994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLGC.2017.04.012

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Darren R Feldman

Devyn T Coskey

Yelena Kemel

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28558987

http://www.w3.org/2001/XMLSchema#string

P932

5771412

http://www.w3.org/2001/XMLSchema#string

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

about

P2860

P2860

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932